Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple ...

Around 1.5 million Brits are now taking weight-loss drugs, such as Mounjaro, and pharmacists are warning users to be careful in the heatwave ...

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

People are reported a certain side effectA urologist has revealed the truth behind ‘Ozempic penis’ after men reported a ...

Bariatric surgeries led to about five-times more weight loss than weekly injections of popular GLP-1 drugs, according to data ...

The side effects of taking Mounjaro can be very varied, and the drug tends to affect people differently. The most common side effects include feeling sick, diarrhoea, constipation, vomiting, heartburn ...

The companies are working together to make it easier for companies to offer health plans that include these medications.

A study by GNC suggests that GLP-1s users are risking malnourishment and muscle loss. GNC announced the results of a study ...

In a statement, a spokesperson for Ozempic manufacturer Novo Nordisk only said that the company has “been working closely with policymakers in Pennsylvania” to ensure continued access ...

This study adds to the growing evidence that while GLP-1 medications can be helpful for some patients, bariatric surgery remains the most powerful option for substantial and lasting weight ...

She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.